Alzheimer's disease is characterized by the accumulation of two main types of abnormal structures in the brain: amyloid plaques and neurofibrillary tangles. Amyloid plaques are made up of beta-amyloid protein fragments that clump together between nerve cells, disrupting communication and triggering inflammation. Neurofibrillary tangles, on the other hand, are twisted fibers of tau protein that build up inside nerve cells, disrupting nutrient transport and cell function.
These pathological changes lead to the progressive degeneration of brain cells, particularly in areas crucial for memory, thinking, and eventually, basic bodily functions. The exact cause of Alzheimer's pathology remains unclear, but genetic, lifestyle, and environmental factors likely play significant roles. Research continues to explore ways to detect, prevent, and treat these underlying mechanisms to ultimately slow down or halt the progression of this devastating disease.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States